SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

NMPA Accepts Innovent’s Sintilimab Application for Advanced Melanoma

China’s NMPA accepted an application for a new indication of sintilimab to treat advanced melanoma.

IVBIY

Related stories